WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
THB 5.20
0.00%
(0.00) 1D
Oct 15, 4:40:00 PM GMT+7 · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WUXI06...
Open
THB 5.25
High
THB 5.35
Low
THB 5.05
Mkt. cap
198.43B
Avg. vol.
93.60K
Volume
288.50K
52-wk high
THB 6.25
52-wk low
THB 3.02
Shares outstanding
4.12B
No. of employees
15K
Open
THB 5.25
High
THB 5.35
Low
THB 5.05
Mkt. cap
198.43B
Avg. vol.
93.60K
Volume
288.50K
52-wk high
THB 6.25
52-wk low
THB 3.02
Shares outstanding
4.12B
No. of employees
15K
News stories
From web sources and news partners
Moomoo
·
12 minutes ago
Dow Jones Top Company Headlines at 3 PM ET: Tesla's New Roadster Takes Flight After Nearly a Decade of Delays
TradingView
·
51 minutes ago
Nasdaq Posts Worst Weekly Drop in Months as Dow Edges to a Narrow Gain
Investor's Business Daily
·
14 minutes ago
9 Dow Jones Stocks Make Bullish Moves In A Defensive Market Rotation
Investopedia
·
3 hours ago
Nasdaq Poised to End Run of Weekly Gains
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About Wuxi Biologics (Cayman) Inc. KKPS DR